The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant ipilimumab and nivolumab in combination with paclitaxel following anthracycline-based chemotherapy in patients with treatment resistant early-stage triple-negative breast cancer (TNBC): A single-arm phase 2 trial.
 
Sherene Loi
Consulting or Advisory Role - Aduro Biotech (Inst); AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Lilly (Inst); G1 Therapeutics (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); PUMA Biotechnology (Inst); Roche/Genentech (Inst); Seagen (Inst); Silverback Therapeutics (Inst); Tallac Therapeutics (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Seagen (Inst)
Other Relationship - Roche Medical writing support
 
Prudence A. Francis
Honoraria - AstraZeneca; Novartis; Novartis
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Nicholas Zdenkowski
Honoraria - AstraZeneca; Eisai; Lilly; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly
Research Funding - Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Novartis; Roche
 
Val Gebski
No Relationships to Disclose
 
Stephen B. Fox
Consulting or Advisory Role - AstraZeneca (Inst); BMS (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); BMS (Inst); Roche (Inst)
Expert Testimony - AstraZeneca (Inst); MSD (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD; Ventana Medical Systems
 
Michelle White
Honoraria - Gilead Sciences
Consulting or Advisory Role - AstraZeneca Canada; Gilead Sciences; Roche
 
Belinda Emma Kiely
Honoraria - Novartis
Consulting or Advisory Role - Gilead Sciences; Roche
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Natasha E. Woodward
Stock and Other Ownership Interests - CSL Limited
Consulting or Advisory Role - Pfizer
Research Funding - Medivation (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Rina Hui
Honoraria - AstraZeneca; Bristol-Myers Squibb; Eisai; Lilly; Merck; Merck Sharp & Dohme; Novartis; Oncosec; Pfizer; Roche; Seagen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; Lilly; Merck; Merck Sharp & Dohme; Novartis; Oncosec; Pfizer; Roche; Seagen
Research Funding - AstraZeneca (Inst); BMSi (Inst); Corvus Pharmaceuticals (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Olema Pharmaceuticals (Inst); OncoSec (Inst); Roche (Inst); Seagen (Inst)
 
Andrew David Redfern
Honoraria - AstraZeneca; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Pfizer; Roche
 
Raewyn Calvert
No Relationships to Disclose
 
Lauren Rennie
No Relationships to Disclose
 
Frances M. Boyle
Honoraria - Eisai; Gilead Sciences; Lilly; Roche
Consulting or Advisory Role - Gilead Sciences; Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis
Other Relationship - Clinical Oncology Society of Australia (COSA); Pamgene; Paxman
(OPTIONAL) Uncompensated Relationships - Paxman; Paxman